Fortress Biotech (FBIO) versus Kamada (KMDA) Critical Contrast

Fortress Biotech (FBIO) versus Kamada (KMDA) Critical Contrast

Fortress Biotech and Kamada are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings. Fortress Biotech has a beta of 1.14, indicating that its stock price is 14% more volatile than the S&P 500.

from Biotech News